The number of shares and votes in Moberg Pharma AB (publ) has increased by 1,081,000 to 11,893,572 during July 2013. Therefore, there are in total 11,893,572 shares and votes in the company as of July 31st, 2013. The increase is a result of a directed share issue of 1,081,000 shares to Bure Equity AB resolved by the board under an authorization from the annual general meeting 2013. The share issue was completed in order for Moberg Pharma to increase its financial flexibility relating to potential acquisition opportunities. About this information Moberg Pharma discloses this information pursuant to the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.30 am (CET) on July 31st, 2013. For additional information contact: Peter Wolpert, CEO, Telephone: +46 (0)70 - 735 71 35 E-mail: peter.wolpert@mobergpharma.se Magnus Persson, IR, Telephone: +46 (0)73 – 355 26 01 E-mail: magnus.persson@mobergpharma.se About Moberg Pharma Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 40 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. The portfolio is developed further through acquisitions and in -licensing of products as well as product development with focus on innovative drug delivery based on proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s share (OMX: MOB) is listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: www.mobergpharma.com.
Change of number of shares and votes in Moberg Pharma The
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Freddie Mac Prepares to Share Q2 2025 Financial Insights
Freddie Mac to Report Financial Results for Q2 2025 MCLEAN, Va. — Freddie Mac (OTCQB:FMCC) has exciting news for its stakeholders. The company plans to unveil its financial results for the second quarter of 2025 ahead of the opening of U.S. financial markets. This important report is set for release on July 31, 2025. Details of the Upcoming Announcement On the same day,...
Continue Reading
Dunamis Premium Spirits Celebrates Heritage with Be-Bianca Contest
Dunamis Premium Spirits Unveils Be-Bianca Contest Dunamis Premium Spirits, a well-regarded craft distillery known for its exceptional collection of premium spirits, has launched an exciting initiative called the "Be-Bianca" Contest. This vibrant campaign is set against the backdrop of Hispanic Heritage Month and aims to honor the strength, beauty, and dynamic spirit of...
Continue Reading
Get Ready for Winter: Generac Provides Cold Weather Tips
Prepare for Cold Weather Power Outages with Generac As winter approaches, it's crucial for homeowners to prepare for the possibility of power outages caused by severe cold weather. Generac Holdings Inc. (NYSE: GNRC), a leader in energy technology solutions, advocates the development of a comprehensive backup power plan to safeguard homes and families against...
Continue Reading
AEG Achieves Perfect Score in Equality Index for 2025
AEG Achieves Perfect Score in Corporate Equality Index AEG, renowned globally as a leader in sports and live entertainment, proudly announced that it has received a remarkable score of 100 on the Human Rights Campaign Foundation’s (HRC) 2025 Corporate Equality Index (CEI). This marks the sixth consecutive year that AEG has been recognized with this outstanding rating,...
Continue Reading
Beyond Meat's Strategic Moves: Early Tender Results and Settlements
Beyond Meat's Recent Tender Offer Developments Beyond Meat, Inc. (NASDAQ: BYND), a notable leader in the plant-based meat industry, has made headlines with its latest exchange offer. This initiative involves transitioning its existing 0% Convertible Senior Notes due 2027 to new financing solutions that promise better terms for the company. Overview of the Exchange Offer...
Continue Reading